Details of the Drug Formulaction

General Information of Drug Formulation (ID: F11365)

Formulation Name

Lenalidomide 20 mg capsule

Company

Celgene Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	Status
Lenalidomide	DM6Q7U4	Adult T-cell leukemia/lymphoma	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	E00099	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium	E00625	Not Available	Disintegrant
Magnesium stearate	E00208	11177	lubricant

--------------------